Horizon Bancorp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Horizon Bancorp's BMY Position: Q2 2026 in Review
Horizon Bancorp increased its Bristol-Myers Squibb (BMY) stake by 2% in Q2 2026, buying an estimated $3.73K and bringing the position to 3,365 shares worth $194K. The position accounts for 0.09% of the portfolio, ranked #80.
Horizon Bancorp first reported a position in BMY in Q4 2019 and has held it in 18 quarters since. The position peaked at $1.42M in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Horizon Bancorp held 3,365 shares of Bristol-Myers Squibb worth $194K as of Q2 2026.
- Horizon Bancorp bought 65 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.73K.
- Bristol-Myers Squibb made up 0.09% of Horizon Bancorp's portfolio in Q2 2026, its #80 holding.
- Horizon Bancorp first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 18 quarters since.
- Horizon Bancorp's Bristol-Myers Squibb position peaked at $1.42M in Q4 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Horizon Bancorp's 13F filing for Q2 2026, filed 4 Aug 2026.